The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tumor stroma percentage (TSP) and intrinsic subtypes in stage II/III colon cancer: NRG Oncology/NSABP C-07 trial.
 
Rim S Kim
No Relationships to Disclose
 
Patrick G Gavin
No Relationships to Disclose
 
Soonmyung Paik
No Relationships to Disclose
 
Carmen Joseph Allegra
No Relationships to Disclose
 
Samuel A. Jacobs
No Relationships to Disclose
 
Katherine L. Pogue-Geile
Patents, Royalties, Other Intellectual Property - The following patent was submitted: U. S. Patent Application Serial No. 14/738,757, entitled: “Methods of Subtyping CRC and their Association with Treatment of Colon Cancer Patients with Oxaliplatin." Published 12/24/15.
 
Peter C. Lucas
Stock and Other Ownership Interests - Amgen
Consulting or Advisory Role - Bayer (I)